A Multistate Investigation of Serious Adverse Events, including Deaths, following Ceftriaxone Injections, September 2024–August 2025
Rebecca Pierce, Radhika Agarwal, Dumbani Kayira, Maribeth C. Lovegrove et autres
BACKGROUND: Reports of ceftriaxone serious adverse events (SAEs), including deaths, from multiple jurisdictions during December 2024-January 2025 prompted a nationwide investigation to evaluate product safety, characterize SAEs, and assess for changes in baseline adverse event occurrence via national databases. METHODS: In February …
us, Ouganda, th (code pays fourni par la source)
0 citations
Clinical Infectious Diseases